Clinical Trials Directory

Trials / Completed

CompletedNCT03764423

Health Effects of Salmon Fishmeal in Humans

Health Effects of Salmon Fishmeal in Humans With Impaired Glucose Tolerance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
University of Oslo · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

Diabetes contributes significantly to the burden of disease in Norway and cardiovascular disease is the main cause of mortality. Both lean and fatty fish are shown to have beneficial health effects. In addition to omega-3 fatty acids, fish contain potential health-promoting components such as taurine, vitamin D, vitamin B12, iodine, selenium and more unspecified components such as bioactive peptides. With the expected growth in the aquaculture sector, more protein-rich by-products will become available. The overall aim of this project is to investigate the health beneficial effects of fish protein in the form of salmon fishmeal in a human intervention study with regard to metabolic risk markers. We will include subjects with impaired glucose tolerance to a randomized controlled parallel study. The subjects will receive capsules with fishmeal or placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSalmon fishmealSalmon fishmeal with high protein content
DIETARY_SUPPLEMENTMicrocrystalline celluloseMicrocrystalline cellulose contain no energy and is less fermented in the gut than other dietary fibers.

Timeline

Start date
2018-09-14
Primary completion
2019-11-01
Completion
2019-11-01
First posted
2018-12-05
Last updated
2021-09-28

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT03764423. Inclusion in this directory is not an endorsement.